Dr. Max O'Donnell Is Joining The RESIST-TB Steering Committee

resisttb
3 hours ago
1 min read

RESIST-TB is excited to share that Dr. Max O'Donnell is joining our steering committee! Max is an Associate Professor of Medicine and Epidemiology at Columbia University Irving Medical Center, where he leads a multidisciplinary research program focused on global health, with particular emphasis on drug-resistant tuberculosis (DR-TB), HIV co-infection, and severe acute respiratory infections. Read more about Max here.

Recent Posts

See All

UVA-Led Team Awarded Grant to Develop Global Resource Supporting Nurses Caring for Drug-Resistant Tuberculosis

Researchers from the University of Virginia have recently received a grant from the Pittsfield Anti-Tuberculosis Association to create a global, web-based resource to further support nurses that are c

6-month drug-resistant tuberculosis treatment more effective, cheaper than existing regimens: ICMR study

A six-month oral treatment for MDR-TB, and also specifically rifampicin-resistant, was found to be both more effective and more cost effective when compared to the longer therapies/medications current

This new, one-two punch could knock out drug-resistant TB

A recent study has demonstrated that rifampicin (a frontline antibiotic for TB) when paired with a second compound called AAP-SO 2 , becomes a more powerful treatment in both suppressing TB resistance

Comments